MedTrace Logo

taVNS for Speech and Language Recovery in Aphasia

NCT07563387 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-05-04

No results posted yet for this study

Summary

The goal of this research study is to evaluate a novel approach to improving speech recovery in those with acquired apraxia of speech. We will enroll participants with apraxia of speech resulting from stroke or brain injury to complete several tasks and intervention. Testing will take place four times over the course of the study and intervention will take place 5 days a week for 16 weeks. Overall, you can expect to spend up to 17 weeks participating in this study.

Conditions

  • Aphasia
  • Apraxia of Speech

Interventions

DEVICE

taVNS

active vagus nerve stimulation

DEVICE

sham taVNS

sham vagus nerve stimulation

Sponsors & Collaborators

  • Eric Sorenson Motor Speech Program at Brooks Rehabilitation

    collaborator UNKNOWN

  • University of Florida

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-01-01
Completion
2028-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07563387 on ClinicalTrials.gov